# Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H

> **NCT02627118** · NA · COMPLETED · sponsor: **UConn Health** · enrollment: 10 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** FRESENIUS 160NR
- **DEVICE:** NIPRO ELISIO-15H

## Key facts

- **NCT ID:** NCT02627118
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-07-11
- **Final completion:** 2016-07-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627118, "Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02627118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*